Pathology Industry in the United States Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 12 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • December 2014
    40 pages
  • Pathology  

    Infectious Dise...  

    Influenza  

  • United States  

    North America  

    Sierra Leone  

View report >

Pathology Description in the US

  • December 2014
    6 pages
  • Hiv  

  • United States  

View report >

Pathology Description in the US, Weekly Update

  • December 2014
    28 pages
  • Malaria  

  • United States  

    North America  

View report >

Pathology Description in the US

  • December 2014
    24 pages
  • Pathology  

  • United States  

    North America  

    Puerto Rico  

View report >

Pathology Description in the US

  • December 2014
    14 pages
  • Pathology  

    Cancer  

    Prostate Cancer  

  • United States  

View report >

Pathology Description in the US - Forecast

  • December 2014
    28 pages
  • Neurological Di...  

  • United States  

View report >

Global Pathology Description

  • December 2014
    24 pages
  • Hiv  

  • United States  

    Africa  

    World  

View report >

Pathology Description in the US - Forecast

  • December 2014
    9 pages
  • Endocrine, Nutr...  

  • United States  

View report >

Pathology Description in the US

  • December 2014
    66 pages
  • Hiv  

  • United States  

    North America  

View report >

Pathology Description in the US

  • December 2014
    11 pages
  • Cancer  

  • United States  

    Germany  

View report >

Search in Pathology Industry

About 1 600 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 8 119)

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8 119
  • Industry report
  • December 2014
  • by Firstword Pharma

The Ulcerative Colitis (UC) treatment market is already undergoing radical change as new, safer products that slow disease progression have come to market or will be launched in the next few years. While ...

Malignant Melanoma: Kol Insight

October 2014 $ 6 495

Kol Insight: Multiple Sclerosis

October 2014 $ 6 495

Payer Insights: Hepatitis C

September 2014 $ 6 495

Pharmapoint: Her2-positive Breast Cancer - Us Drug Fore ...

September 2014 $ 4 995

Epicast Report: Rheumatoid Arthritis - Epidemiology For ...

December 2014 $ 3 995

Epicast Report: Celiac Disease - Epidemiology Forecast ...

November 2014 $ 3 995

Epicast Report: Type 1 Diabetes - Epidemiology Forecast ...

November 2014 $ 3 995

Epicast Report: Irritable Bowel Syndrome - Epidemiology ...

October 2014 $ 3 995

Epicast Report: Cushing's Syndrome - Epidemiology Forec ...

October 2014 $ 3 995


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.